New Haven’s Biohaven Pharmaceutical Holding Co., a privately held, clinical stage biopharmaceutical firm, has completed the second round of a previously disclosed $80 million private financing deal.

Biohaven has now raised more than $100 million in private capital since its inception in 2014.

more